Neural organoids and 3D spheroids are a fast-evolving technology with enormous potential for studying brain development and neuronal disorders.
They offer a more sophisticated and physiologically relevant system for fundamental research and high-throughput drug discovery, including chemical profiling and toxicity assessment.
This app note demonstrates how to assemble normal human iPSC-derived cell types such as glutamatergic neurons, GABAergic neurons, and astrocytes into 3D neurospheres for chemical profiling.
Image Credit: Molecular Devices
Download the App Note
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.